Impact of pretransplant hyponatremia on outcome following liver transplantation

Hepatology

Volumn 49, Issue 5, 2009, Pages 1610-1615

  Yun, Byung Cheol ^a   Kim, W Ray ^a   Benson, Joanne T ^a   Biggins, Scott W ^b   Therneau, Terry M ^a   Kremers, Walter K ^a   Rosen, Charles B ^a   Klintmalm, Goran B ^c  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM;

ADULT; ARTICLE; CENTRAL PONTINE MYELINOLYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; HYPONATREMIA; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SURVIVAL RATE; BLOOD; CLINICAL TRIAL; INTENSIVE CARE; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; STATISTICS; UNITED STATES;

ADULT; FEMALE; HUMANS; HYPONATREMIA; INCIDENCE; INTENSIVE CARE; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYELINOLYSIS, CENTRAL PONTINE; POSTOPERATIVE COMPLICATIONS; SODIUM; UNITED STATES;

EID: 66149107027     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22846     Document Type: Article

References (32)

1. Arroyo V, Rodes J, Gutierrez-Lizarraga MA, Revert L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis 1976; 2:249-256.
2. Angeli P, Wong F, Watson H, Gines P. Hyponatremia in cirrhosis: Results of a patient population survey. HEPATOLOGY 2006;44:1535-1542.
3. Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W, et al. Hyponatremia in cirrhosis: From pathogenesis to treatment. HEPATOLOGY 1998;28:851-864.
4. Bichet D, Szatalowicz V, Chaimovitz C, Schrier RW. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann Intern Med 1982; 96:413-417.
5. Epstein M. Derangements of renal water handling in liver disease. Gastroenterology 1985;89:1415-1425.
6. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. HEPATOLOGY 1988;8:1151-1157.
7. Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94:482-487.
8. Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol 2001;34:46-52.
9. Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162:323-328.
10. Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis 2000;32:605-610.
11. Gines A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229-236.
12. Cosby RL, Yee B, Schrier RW. New classification with prognostic value in cirrhotic patients. Miner Electrolyte Metab 1989;15:261-266.
13. Shear L, Kleinerman J, Gabuzda GJ. Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am J Med 1965;39: 184-198.
14. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006;130:1652-1660.
15. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001;33:464-470.
16. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
17. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. HEPATOLOGY 2004;40:802-810.
18. Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver transplantation. HEPATOLOGY 2005;41:32-39.
19. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005;11:336-343.
20. Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE. The impact of serum sodium concentration on mortality after liver transplantation: A cohort multicenter study. Liver Transpl 2007;13:1115-1124.
21. Yu J, Liang TB, Zheng SS, Shen Y, Wang WL, Ke QH. The possible causes of central pontine myelinolysis after liver transplantation. [in Chinese] Zhonghua Wai Ke Za Zhi 2004;42:1048-1051.
22. Londono MC, Guevara M, Rimola A, Navasa M, Taura P, Mas A, et al. Hyponatremia impairs early post transplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006;130: 1135-1143.
23. Abbasoglu O, Goldstein RM, Vodapally MS, Jennings LW, Levy MF, Husberg BS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant 1998;12:263-269.
24. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342:1581-1589.
25. Hoorn EJ, Lindemans J, Zietse R. Acute and concomitant deterioration of hyponatremia and renal dysfunction associated with heart and liver failure. Clin Nephrol 2006;65:248-255.
26. Gonzalez E, Rimola A, Navasa M, Andreu H, Grande L, Garcia-Valdecasas JC, et al. Liver transplantation in patients with non-biliary cirrhosis: prognostic value of preoperative factors. J Hepatol 1998;28:320-328.
27. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886-897.
28. Esteva-Font C, Baccaro ME, Fernandez-Llama P, Sans L, Guevara M, Ars E, et al. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: relationship with ascites and hepatorenal syndrome. HEPATOLOGY 2006;44: 1555-1563.
29. Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, et al. Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99-106.
30. Ioannou GN. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006;12:1594-1606.
31. Wszolek ZK, McComb RD, Pfeiffer RF, Steg RE, Wood RP, Shaw BW Jr, et al. Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. Transplantation 1989;48: 1006-1012.
32. Pujol A, Graus F, Rimola A, Beltran J, Garcia-Valdecasas JC, Navasa M, et al. Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994;44:1226-1230.